Adjuvant taxanes and the development of breast cancer-related arm lymphoedema.
Identifieur interne : 002175 ( Main/Exploration ); précédent : 002174; suivant : 002176Adjuvant taxanes and the development of breast cancer-related arm lymphoedema.
Auteurs : M. Cariati [Royaume-Uni] ; S K Bains [Royaume-Uni] ; M R Grootendorst [Royaume-Uni] ; A. Suyoi [Royaume-Uni] ; A M Peters [Royaume-Uni] ; Peter Mortimer (dermatologue) [Royaume-Uni] ; P. Ellis [Royaume-Uni] ; M. Harries [Royaume-Uni] ; M. Van Hemelrijck [Royaume-Uni] ; A D Purushotham [Royaume-Uni]Source :
- The British journal of surgery [ 1365-2168 ] ; 2015.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Aisselle, Antinéoplasiques (effets indésirables), Bras, Complications postopératoires (), Facteurs de risque, Femelle, Humains, Lymphadénectomie, Lymphoedème (), Mastectomie, Modèles de hasards proportionnels, Résultat thérapeutique, Sujet âgé, Taxoïdes (effets indésirables), Traitement médicamenteux adjuvant, Tumeurs du sein (), Tumeurs du sein (traitement médicamenteux), Études de cohortes, Études rétrospectives.
- MESH :
- effets indésirables : Antinéoplasiques, Taxoïdes.
- traitement médicamenteux : Tumeurs du sein.
- Adulte, Adulte d'âge moyen, Aisselle, Bras, Complications postopératoires, Facteurs de risque, Femelle, Humains, Lymphadénectomie, Lymphoedème, Mastectomie, Modèles de hasards proportionnels, Résultat thérapeutique, Sujet âgé, Traitement médicamenteux adjuvant, Tumeurs du sein, Études de cohortes, Études rétrospectives.
English descriptors
- KwdEn :
- Adult, Aged, Antineoplastic Agents (adverse effects), Arm, Axilla, Breast Neoplasms (drug therapy), Breast Neoplasms (surgery), Chemotherapy, Adjuvant, Cohort Studies, Female, Humans, Lymph Node Excision, Lymphedema (chemically induced), Mastectomy, Middle Aged, Postoperative Complications (chemically induced), Proportional Hazards Models, Retrospective Studies, Risk Factors, Taxoids (adverse effects), Treatment Outcome.
- MESH :
- chemical , adverse effects : Antineoplastic Agents, Taxoids.
- chemically induced : Lymphedema, Postoperative Complications.
- drug therapy : Breast Neoplasms.
- surgery : Breast Neoplasms.
- Adult, Aged, Arm, Axilla, Chemotherapy, Adjuvant, Cohort Studies, Female, Humans, Lymph Node Excision, Mastectomy, Middle Aged, Proportional Hazards Models, Retrospective Studies, Risk Factors, Treatment Outcome.
Abstract
Despite affecting approximately one-quarter of all patients undergoing axillary lymph node dissection, the pathophysiology of breast cancer-related lymphoedema (BCRL) remains poorly understood. More extensive locoregional treatment and higher body mass index have long been identified as major risk factors. This study aimed to identify risk factors for BCRL with a specific focus on the potential impact of chemotherapy on the risk of BCRL.
DOI: 10.1002/bjs.9846
PubMed: 26040263
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000E55
- to stream PubMed, to step Curation: 000E55
- to stream PubMed, to step Checkpoint: 000E55
- to stream Ncbi, to step Merge: 007455
- to stream Ncbi, to step Curation: 007455
- to stream Ncbi, to step Checkpoint: 007455
- to stream Main, to step Merge: 002178
- to stream Main, to step Curation: 002175
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Adjuvant taxanes and the development of breast cancer-related arm lymphoedema.</title><author><name sortKey="Cariati, M" sort="Cariati, M" uniqKey="Cariati M" first="M" last="Cariati">M. Cariati</name><affiliation wicri:level="3"><nlm:affiliation>Section of Research Oncology, King's College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Section of Research Oncology, King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Bains, S K" sort="Bains, S K" uniqKey="Bains S" first="S K" last="Bains">S K Bains</name><affiliation wicri:level="3"><nlm:affiliation>Section of Research Oncology, King's College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Section of Research Oncology, King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Grootendorst, M R" sort="Grootendorst, M R" uniqKey="Grootendorst M" first="M R" last="Grootendorst">M R Grootendorst</name><affiliation wicri:level="3"><nlm:affiliation>Section of Research Oncology, King's College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Section of Research Oncology, King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Suyoi, A" sort="Suyoi, A" uniqKey="Suyoi A" first="A" last="Suyoi">A. Suyoi</name><affiliation wicri:level="3"><nlm:affiliation>Directorate of Haematology and Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Directorate of Haematology and Oncology, Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Peters, A M" sort="Peters, A M" uniqKey="Peters A" first="A M" last="Peters">A M Peters</name><affiliation wicri:level="1"><nlm:affiliation>Department of Nuclear Medicine, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Nuclear Medicine, Brighton and Sussex University Hospitals NHS Trust, Brighton</wicri:regionArea><wicri:noRegion>Brighton</wicri:noRegion></affiliation></author><author><name sortKey="Mortimer, P" sort="Mortimer, P" uniqKey="Mortimer P" first="P" last="Mortimer">Peter Mortimer (dermatologue)</name><affiliation wicri:level="4"><nlm:affiliation>Department of Clinical Sciences, St George's, University of London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Clinical Sciences, St George's, University of London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">Université de Londres</orgName><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName><orgName type="university">Université de Londres</orgName></affiliation></author><author><name sortKey="Ellis, P" sort="Ellis, P" uniqKey="Ellis P" first="P" last="Ellis">P. Ellis</name><affiliation wicri:level="3"><nlm:affiliation>Section of Research Oncology, King's College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Section of Research Oncology, King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Harries, M" sort="Harries, M" uniqKey="Harries M" first="M" last="Harries">M. Harries</name><affiliation wicri:level="3"><nlm:affiliation>Section of Research Oncology, King's College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Section of Research Oncology, King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Van Hemelrijck, M" sort="Van Hemelrijck, M" uniqKey="Van Hemelrijck M" first="M" last="Van Hemelrijck">M. Van Hemelrijck</name><affiliation wicri:level="3"><nlm:affiliation>School of Medicine, Cancer Epidemiology Group, Division of Cancer Studies, King's College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>School of Medicine, Cancer Epidemiology Group, Division of Cancer Studies, King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Purushotham, A D" sort="Purushotham, A D" uniqKey="Purushotham A" first="A D" last="Purushotham">A D Purushotham</name><affiliation wicri:level="3"><nlm:affiliation>Section of Research Oncology, King's College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Section of Research Oncology, King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26040263</idno><idno type="pmid">26040263</idno><idno type="doi">10.1002/bjs.9846</idno><idno type="wicri:Area/PubMed/Corpus">000E55</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000E55</idno><idno type="wicri:Area/PubMed/Curation">000E55</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000E55</idno><idno type="wicri:Area/PubMed/Checkpoint">000E55</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000E55</idno><idno type="wicri:Area/Ncbi/Merge">007455</idno><idno type="wicri:Area/Ncbi/Curation">007455</idno><idno type="wicri:Area/Ncbi/Checkpoint">007455</idno><idno type="wicri:Area/Main/Merge">002178</idno><idno type="wicri:Area/Main/Curation">002175</idno><idno type="wicri:Area/Main/Exploration">002175</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Adjuvant taxanes and the development of breast cancer-related arm lymphoedema.</title><author><name sortKey="Cariati, M" sort="Cariati, M" uniqKey="Cariati M" first="M" last="Cariati">M. Cariati</name><affiliation wicri:level="3"><nlm:affiliation>Section of Research Oncology, King's College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Section of Research Oncology, King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Bains, S K" sort="Bains, S K" uniqKey="Bains S" first="S K" last="Bains">S K Bains</name><affiliation wicri:level="3"><nlm:affiliation>Section of Research Oncology, King's College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Section of Research Oncology, King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Grootendorst, M R" sort="Grootendorst, M R" uniqKey="Grootendorst M" first="M R" last="Grootendorst">M R Grootendorst</name><affiliation wicri:level="3"><nlm:affiliation>Section of Research Oncology, King's College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Section of Research Oncology, King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Suyoi, A" sort="Suyoi, A" uniqKey="Suyoi A" first="A" last="Suyoi">A. Suyoi</name><affiliation wicri:level="3"><nlm:affiliation>Directorate of Haematology and Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Directorate of Haematology and Oncology, Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Peters, A M" sort="Peters, A M" uniqKey="Peters A" first="A M" last="Peters">A M Peters</name><affiliation wicri:level="1"><nlm:affiliation>Department of Nuclear Medicine, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Nuclear Medicine, Brighton and Sussex University Hospitals NHS Trust, Brighton</wicri:regionArea><wicri:noRegion>Brighton</wicri:noRegion></affiliation></author><author><name sortKey="Mortimer, P" sort="Mortimer, P" uniqKey="Mortimer P" first="P" last="Mortimer">Peter Mortimer (dermatologue)</name><affiliation wicri:level="4"><nlm:affiliation>Department of Clinical Sciences, St George's, University of London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Clinical Sciences, St George's, University of London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">Université de Londres</orgName><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName><orgName type="university">Université de Londres</orgName></affiliation></author><author><name sortKey="Ellis, P" sort="Ellis, P" uniqKey="Ellis P" first="P" last="Ellis">P. Ellis</name><affiliation wicri:level="3"><nlm:affiliation>Section of Research Oncology, King's College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Section of Research Oncology, King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Harries, M" sort="Harries, M" uniqKey="Harries M" first="M" last="Harries">M. Harries</name><affiliation wicri:level="3"><nlm:affiliation>Section of Research Oncology, King's College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Section of Research Oncology, King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Van Hemelrijck, M" sort="Van Hemelrijck, M" uniqKey="Van Hemelrijck M" first="M" last="Van Hemelrijck">M. Van Hemelrijck</name><affiliation wicri:level="3"><nlm:affiliation>School of Medicine, Cancer Epidemiology Group, Division of Cancer Studies, King's College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>School of Medicine, Cancer Epidemiology Group, Division of Cancer Studies, King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Purushotham, A D" sort="Purushotham, A D" uniqKey="Purushotham A" first="A D" last="Purushotham">A D Purushotham</name><affiliation wicri:level="3"><nlm:affiliation>Section of Research Oncology, King's College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Section of Research Oncology, King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></analytic><series><title level="j">The British journal of surgery</title><idno type="eISSN">1365-2168</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Antineoplastic Agents (adverse effects)</term><term>Arm</term><term>Axilla</term><term>Breast Neoplasms (drug therapy)</term><term>Breast Neoplasms (surgery)</term><term>Chemotherapy, Adjuvant</term><term>Cohort Studies</term><term>Female</term><term>Humans</term><term>Lymph Node Excision</term><term>Lymphedema (chemically induced)</term><term>Mastectomy</term><term>Middle Aged</term><term>Postoperative Complications (chemically induced)</term><term>Proportional Hazards Models</term><term>Retrospective Studies</term><term>Risk Factors</term><term>Taxoids (adverse effects)</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aisselle</term><term>Antinéoplasiques (effets indésirables)</term><term>Bras</term><term>Complications postopératoires ()</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie</term><term>Lymphoedème ()</term><term>Mastectomie</term><term>Modèles de hasards proportionnels</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Taxoïdes (effets indésirables)</term><term>Traitement médicamenteux adjuvant</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (traitement médicamenteux)</term><term>Études de cohortes</term><term>Études rétrospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Agents</term><term>Taxoids</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Lymphedema</term><term>Postoperative Complications</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antinéoplasiques</term><term>Taxoïdes</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Arm</term><term>Axilla</term><term>Chemotherapy, Adjuvant</term><term>Cohort Studies</term><term>Female</term><term>Humans</term><term>Lymph Node Excision</term><term>Mastectomy</term><term>Middle Aged</term><term>Proportional Hazards Models</term><term>Retrospective Studies</term><term>Risk Factors</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aisselle</term><term>Bras</term><term>Complications postopératoires</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie</term><term>Lymphoedème</term><term>Mastectomie</term><term>Modèles de hasards proportionnels</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Traitement médicamenteux adjuvant</term><term>Tumeurs du sein</term><term>Études de cohortes</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Despite affecting approximately one-quarter of all patients undergoing axillary lymph node dissection, the pathophysiology of breast cancer-related lymphoedema (BCRL) remains poorly understood. More extensive locoregional treatment and higher body mass index have long been identified as major risk factors. This study aimed to identify risk factors for BCRL with a specific focus on the potential impact of chemotherapy on the risk of BCRL.</div></front></TEI><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li></region><settlement><li>Londres</li></settlement><orgName><li>Université de Londres</li></orgName></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Cariati, M" sort="Cariati, M" uniqKey="Cariati M" first="M" last="Cariati">M. Cariati</name></region><name sortKey="Bains, S K" sort="Bains, S K" uniqKey="Bains S" first="S K" last="Bains">S K Bains</name><name sortKey="Ellis, P" sort="Ellis, P" uniqKey="Ellis P" first="P" last="Ellis">P. Ellis</name><name sortKey="Grootendorst, M R" sort="Grootendorst, M R" uniqKey="Grootendorst M" first="M R" last="Grootendorst">M R Grootendorst</name><name sortKey="Harries, M" sort="Harries, M" uniqKey="Harries M" first="M" last="Harries">M. Harries</name><name sortKey="Mortimer, P" sort="Mortimer, P" uniqKey="Mortimer P" first="P" last="Mortimer">Peter Mortimer (dermatologue)</name><name sortKey="Peters, A M" sort="Peters, A M" uniqKey="Peters A" first="A M" last="Peters">A M Peters</name><name sortKey="Purushotham, A D" sort="Purushotham, A D" uniqKey="Purushotham A" first="A D" last="Purushotham">A D Purushotham</name><name sortKey="Suyoi, A" sort="Suyoi, A" uniqKey="Suyoi A" first="A" last="Suyoi">A. Suyoi</name><name sortKey="Van Hemelrijck, M" sort="Van Hemelrijck, M" uniqKey="Van Hemelrijck M" first="M" last="Van Hemelrijck">M. Van Hemelrijck</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002175 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002175 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26040263
|texte= Adjuvant taxanes and the development of breast cancer-related arm lymphoedema.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26040263" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |